Inogen (INGN) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Inogen (INGN) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 189.50% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -54.61% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -6.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | 88.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.51% |
| Dec 31, 2025 | 94.91% |
| Sep 30, 2025 | 69.78% |
| Jun 30, 2025 | 97.01% |
| Mar 31, 2025 | -563.80% |
| Dec 31, 2024 | 75.15% |
| Sep 30, 2024 | 81.40% |
| Jun 30, 2024 | -518.15% |
| Mar 31, 2024 | 94.41% |
| Dec 31, 2023 | 57.80% |
| Sep 30, 2023 | 45.10% |
| Jun 30, 2023 | 62.33% |
| Mar 31, 2023 | -103.05% |
| Dec 31, 2022 | 97.41% |
| Sep 30, 2022 | -1,743.44% |
| Jun 30, 2022 | -454.32% |
| Mar 31, 2022 | -5,641.56% |
| Sep 30, 2021 | 119.27% |
| Jun 30, 2021 | 118.81% |
| Mar 31, 2021 | 97.20% |